Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis

This study has been completed.
Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Cervical Cancer
			Colorectal Cancer
			Diarrhea
			Endometrial Cancer
			Fallopian Tube Cancer
			Ovarian Cancer
			Prostate Cancer
			Sarcoma
			Vaginal Cancer
			Vulvar Cancer
2		Additional conditions recognized in this trial
			Colorectal Neoplasms
			Endometrial Neoplasms
			Fallopian Tube Neoplasms
			Ovarian Neoplasms
			Prostatic Neoplasms
			Uterine Cervical Neoplasms
			Vaginal Neoplasms
			Vulvar Neoplasms
3		More general conditions related to this trial
			Adnexal Diseases
			Colonic Diseases
			Digestive System Diseases
			Digestive System Neoplasms
			Endocrine Gland Neoplasms
			Endocrine System Diseases
			Fallopian Tube Diseases
			Gastrointestinal Diseases
			Gastrointestinal Neoplasms
			Genital Diseases, Female
			Genital Diseases, Male
			Genital Neoplasms, Female
			Genital Neoplasms, Male
			Gonadal Disorders
			Intestinal Diseases
			Intestinal Neoplasms
			Neoplasms
			Neoplasms by Histologic Type
			Neoplasms by Site
			Neoplasms, Connective and Soft Tissue
			Ovarian Diseases
			Prostatic Diseases
			Rectal Diseases
			Signs and Symptoms
			Signs and Symptoms, Digestive
			Urogenital Neoplasms
			Uterine Cervical Diseases
			Uterine Diseases
			Uterine Neoplasms
			Vaginal Diseases
			Vulvar Diseases
4		Interventions listed in this trial
			octreotide acetate
5		Additional drug interventions recognized in this trial
			Octreotide
6		More general drug interventions related to this trial
			Antineoplastic Agents
			Antineoplastic Agents, Hormonal
			Gastrointestinal Agents
			Pharmacologic Actions
			Therapeutic Uses
7		Sponsors listed in this trial
			North Central Cancer Treatment Group
			National Cancer Institute (NCI)